Table: begin end state 1 14 cytoplasmic 15 37 transmembrane 38 48 non-cytoplasmic 49 67 transmembrane 68 96 cytoplasmic 97 114 transmembrane 115 119 non-cytoplasmic 120 142 transmembrane 143 148 cytoplasmic 149 168 transmembrane 169 173 non-cytoplasmic 174 194 transmembrane 195 200 cytoplasmic 201 221 transmembrane 222 266 non-cytoplasmic 267 284 transmembrane 285 315 cytoplasmic 316 341 transmembrane 342 353 non-cytoplasmic 354 380 transmembrane 381 388 cytoplasmic 389 407 transmembrane 408 427 non-cytoplasmic
Input: >PfGW456L13_122 Branched-chain amino acid transport system permease protein LivM (TC 3.A.1.4.1) MSSTTKKTIDLKRSLVDAILAGLVALIVFGPIVGVVLDGYGFNMETSRVAWIVAIVMAGR FALSLFLQTPKGLRILEGFETTGSGVHVLPPDYKSRLRWIIPLMIVIAVVFPFFSNSYLL GVVILGLIYVLLGLGLNIVVGLAGLLDLGYVAFYAIGAYGLALGYQYLGLGFWTVLPLAA ITAGLAGCILGFPVLRLHGDYLAIVTLGFGEIIRLILNNWLTLTGGPNGMAAPLPTFFGI EFGKRAKEGGVPFHEFFGIAYNPDVKYYFIYAVLFLVVLAVLHIKHRLTRMPVGRAWEAL REDEIACRSMGLNHVLVKLSAFTIGASTAGLAGVFFATYQGFVNPTSFTFFESALILAIV VLGGMGSTIGVVIAAFVLTVAPELLRGFAEYRVLLFGILMVLMMIWRPRGLIRISRTGVT PRKGVAP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server